AKBANasdaq United States
Market cap
$252.139 M
$0.91 -4.66%
Close of 7 Aug 2026
Revenue
$236.2M
#2245 by revenue
Earnings
-$5.30M
Loss-making
Shares outstanding
277,106,245
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Akebia Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.